Company profile
Matinas BioPharma Holdings, Inc. Insider Trading
MTNBEvery SEC Form 4 insider trading filing for Matinas BioPharma Holdings, Inc. (MTNB) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Pharmaceutical Preparations
- CIK
- 0001582554
- Filings
- 22
- Insiders
- 20
- Last filing
- 2026-07-10
Activity summary
No insider transactions in the last 30 days. The most recent was on July 10, 2026, when Stern Adam K sold 344,710 shares. 22 filings from 20 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q4 23 to Q3 26. Matinas BioPharma Holdings, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.7M.
90 day insight
Over the last 90 days, Matinas BioPharma Holdings, Inc. insiders bought $341K across 2 transactions with no open-market sales.
- Most active insider: Stern Adam K with 7 transactions totaling $1.1M.
- Largest single purchase: $221K by Stern Adam K on Jul 10, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Stern Adam K | MTNB | X | 344,710 | $0.35 | $121K |
| Jul 10, 2026 | Stern Adam K | MTNB | J | 141,462 | $0.35 | $50K |
| Jul 10, 2026 | Stern Adam K | MTNB | Award | 344,710 | $0.35 | $121K |
| Jul 10, 2026 | Stern Adam K | MTNB | X | 344,710 | $0.35 | $121K |
| Jul 10, 2026 | Stern Adam K | MTNB | Award | 630,335 | $0.35 | $221K |
31 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=MTNB" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Matinas BioPharma Holdings, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →